1.2400
0.0000
(0.00%)
At close: January 29 at 3:00:00 PM EST
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
6,105.8930
7,092.6090
8,520.4100
2,664.5840
Total Liabilities Net Minority Interest
3,324.8870
3,849.0890
352.8410
1,788.9030
Total Equity Gross Minority Interest
2,781.0060
3,243.5200
8,167.5690
875.6810
Total Capitalization
2,818.7290
3,275.4280
8,191.8090
890.8390
Common Stock Equity
2,818.7290
3,275.4280
8,191.8090
890.8390
Capital Lease Obligations
2,945.8860
3,422.8350
10.1520
48.7540
Net Tangible Assets
2,377.2360
2,833.9350
7,750.3160
635.8840
Working Capital
1,517.5290
1,846.3710
6,786.3480
138.3960
Invested Capital
2,818.7290
3,275.4280
8,191.8090
2,470.2170
Tangible Book Value
2,377.2360
2,833.9350
7,750.3160
635.8840
Total Debt
2,945.8860
3,422.8350
10.1520
1,628.1320
Share Issued
1,175,565.9880
979,749.3210
979,749.3210
433,636.2550
Ordinary Shares Number
1,175,565.9880
979,749.3210
979,749.3210
433,636.2550
12/31/2020 - 1/12/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
INBX Inhibrx Biosciences, Inc.
13.55
+10.07%
MRNS Marinus Pharmaceuticals, Inc.
0.5406
-0.48%
APLS Apellis Pharmaceuticals, Inc.
30.39
+3.12%
ENTX Entera Bio Ltd.
2.3300
-2.10%
QNCX Quince Therapeutics, Inc.
1.6000
-2.44%
TARS Tarsus Pharmaceuticals, Inc.
51.74
-2.51%
NFX.L Nuformix plc
0.0750
-11.76%
IMUX Immunic, Inc.
1.0200
+3.03%
ANTX AN2 Therapeutics, Inc.
1.1700
-0.85%
JSPR Jasper Therapeutics, Inc.
6.70
+15.92%